Investors

Notice of the unsecured creditors meeting as directed by the NCLT to seek approval for the amalgamation of Madaus Pharmaceuticals Private Limited with Mylan Laboratories Limited

Notice of 33rd Annual General Meeting

Notice of Extra ordinary general Meeting-28-June-2017

Notice of Annual General Meeting-16-Dec-2016

Notice of Extra ordinary general meeting-30-Sep-2016


General Information on bonds
Total unsecured, redeemable non-convertible bonds issued: 2,48,034
Face value of each bond: INR 1,00,000/-
Name of the bond holder: Mylan Luxembourg S.A.R.L.
Bonds listed on: Bombay Stock Exchange Limited
Default by issuer to pay interest on or redemption amount on bonds: Not applicable
Failure to create charge on the assets: Not applicable
Current revised rating assigned to non-convertible debt securities: CRISIL AA-/Negative

 

Contact information for investor grievances and grievances for CSR programs:
B. Nagaraj Goud,
Company Secretary and Associate Vice President – Compliance
Mylan Laboratories Limited
Plot No. 564/A/A22, Road No. 92,
Jubilee Hills, Hyderabad. Pin: 500 034, Telangana, India
Email: Nagaraj.bodige@mylan.in
Telephone: +91 40 3086 6088

 

Debenture trustee contact:
Mithil Pattani
Axis Trustee Services Limited,
Axis House, Bombay Dyeing Mills Compound,
Pandurang Budhkar Marg,
Worli, Mumbai Pin: 400 025
Maharashtra
Email: mithil.pattani@axistrustee.com
Telephone: +91 22 2425 5215 | 5216
Fax: +91 22 2425 4200

Financial information for the financial year 2014 - 2015: Please click here to access Directors' Report and the Independent Auditors' Report.